BRAF and pilocytic astrocytoma: Hawkins et al. have reported BRAF-KIAA1549 fusion in 62% of patients with pilocytic astrocytomas; the patients with this fusion had a much better five-year progression-free survival than those without BRAF-KIAA1549 fusion tumors [117].